Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Albera (Turin, Italy). Challenges in IPF trials: the point on endpoints. Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary fibrosis: ongoing trials and future treatment Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 IPF: clinical profiles Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis Year: 2010 Therapeutic options for IPF Source: Annual Congress 2010 - PG1 Core Curriculum Postgraduate Course: Idiopathic pulmonary fibrosis Year: 2010 Endpoints in IPF and lung cancer trials: controversies and perspectives Source: Research Seminar 2015 Year: 2015 Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough Source: Eur Respir J 2015; 46: 607-614 Year: 2015 Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection. Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 The diagnosis of IPF: recommendations & rationale Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Late-breaking abstract: Sildenafil for chronic obstructive pulmonary disease: A randomized crossover trial Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 Compliance with guidelines for pharmacological treatment of COPD: Real-life analyses Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 How to treat IPF: lessons from the NIH-IPF-Net treatment trials Source: International Congress 2014 – Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award 2014 - Hot Topic: "Understanding and treating idiopathic pulmonary fibrosis (IPF) in the 21st century" Year: 2014 Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011 Roflumilast for stable COPD: Meta-analysis of randomized controlled trials Source: International Congress 2014 – Clinical presentations Year: 2014 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Genetic studies in asthma and COPD: what have we learned? Source: Annual Congress 2011 - PG5 Asthma versus COPD: similarities and differences Year: 2011 Outcomes for COPD pharmacological trials: from lung function to Biomarkers Source: ERS Live 2008 Year: 2008